Rapid CRISPR–Cas9 target-strand nicking can provide phage resistance by reducing DNA abundance
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf900 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Giang T Nguyen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Roy J. Carver Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, IA 50011, United States. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Bacteriophages, CRISPR-Associated Protein 9, DNA, Viral. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, National Science Foundation.
Abstract (Originalsprache)
Cas9 is an RNA-guided immune endonuclease that provides bacterial defense against bacteriophages. Cas9 relies on divalent metal ions for cleavage catalysis by two domains, HNH and RuvC, and to facilitate conformational changes that are required for cleavage activation. While Cas9 typically produces double-strand breaks (DSBs) in DNA targets, we observed that reduced, physiologically relevant Mg2+ concentrations can result in a slow rate of non-target strand cleavage by RuvC. This raised the question of whether rapid target-strand nicking by the Cas9 HNH domain is sufficient to provide protection against phage. To address this, we tested phage protection by Cas9 nickases, in which only the HNH or RuvC domain is catalytically active. We find that nicking by HNH, but not RuvC, can be sufficient to provide immunity. Target-strand nicking prevents phage DNA accumulation and can reduce the susceptibility of Cas9 to viral escape. Cleavage by RuvC is strongly impaired in the presence of other biomolecules that can compete for binding of free Mg2+, preventing formation of a DSB. Overall, our results suggest that HNH cleavage may occur more rapidly than RuvC cleavage under physiological conditions, resulting in an initial target-strand nick that may be sufficient to provide CRISPR-mediated immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Roy J. Carver Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, IA 50011, United States.
ORCID-Profile: Dipali G Sashital
Förderung
- NIGMS NIH HHS
- NIH HHS
- National Science Foundation
- National Institutes of Health
Zitieren
APA
Nguyen, G. T., Raju, A., Schelling, M. A., & Sashital, D. G. (2025). Rapid CRISPR–Cas9 target-strand nicking can provide phage resistance by reducing DNA abundance. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf900
Vancouver
Nguyen GT, Raju A, Schelling MA, Sashital DG. Rapid CRISPR–Cas9 target-strand nicking can provide phage resistance by reducing DNA abundance. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf900
BibTeX
@article{Nguyen2025,
author = {Nguyen, Giang T and Raju, Akshara and Schelling, Michael A and Sashital, Dipali G},
title = {Rapid CRISPR–Cas9 target-strand nicking can provide phage resistance by reducing DNA abundance},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf900}
}
EUVIMED